Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Bromoacetylcholine bromide (CAS 22004-27-9)

0.0(0)
Write a reviewAsk a question

Application:
Bromoacetylcholine bromide is an affinity alkylating agent for nicotinic receptors
CAS Number:
22004-27-9
Molecular Weight:
305.01
Molecular Formula:
C7H15BrNO2•Br
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

This chemical is characterized by the presence of a bromoacetyl group attached to the nitrogen atom of choline, along with a bromide ion as its counterion. Its molecular structure combines elements of acetylcholine with an added bromine atom, resulting in a compound that retains the quaternary ammonium group characteristic of choline derivatives, but with increased reactivity due to the bromoacetyl moiety. In terms of its physical appearance, bromoacetylcholine bromide is typically presented as a white or off-white crystalline solid. The bromoacetyl group significantly alters its chemical properties compared to acetylcholine, making it more reactive, particularly in organic synthesis and chemical reactions where the bromine atom can act as a leaving group or participate in nucleophilic substitution reactions. The compound finds its use primarily in biochemical research and chemical synthesis. In research applications, it can be employed in the study of biochemical pathways involving acetylcholine or as a precursor for synthesizing more complex molecules. Its reactivity with nucleophiles, and the potential to form stable covalent bonds with biological molecules, makes it useful in the synthesis of chemical probes or in the modification of biomolecules for analytical purposes.


Bromoacetylcholine bromide (CAS 22004-27-9) References

  1. Rearrangement of nicotinic receptor alpha subunits during formation of the ligand binding sites.  |  Mitra, M., et al. 2001. J Neurosci. 21: 3000-8. PMID: 11312284
  2. Assessing the lipid requirements of the Torpedo californica nicotinic acetylcholine receptor.  |  Hamouda, AK., et al. 2006. Biochemistry. 45: 4327-37. PMID: 16566607
  3. Identifying the lipid-protein interface of the alpha4beta2 neuronal nicotinic acetylcholine receptor: hydrophobic photolabeling studies with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine.  |  Hamouda, AK., et al. 2007. Biochemistry. 46: 13837-46. PMID: 17994769
  4. Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies.  |  Sanghvi, M., et al. 2008. Biochim Biophys Acta. 1778: 2690-9. PMID: 18817747
  5. Is acetylcholine an autocrine/paracrine growth factor via the nicotinic alpha7-receptor subtype in the human colon cancer cell line HT-29?  |  Pettersson, A., et al. 2009. Eur J Pharmacol. 609: 27-33. PMID: 19285065
  6. [(3)H]Epibatidine photolabels non-equivalent amino acids in the agonist binding site of Torpedo and alpha4beta2 nicotinic acetylcholine receptors.  |  Srivastava, S., et al. 2009. J Biol Chem. 284: 24939-47. PMID: 19620239
  7. A pharmacological analysis of the cholinergic regulation of urokinase-type plasminogen activator secretion in the human colon cancer cell line, HT-29.  |  Novotny, A., et al. 2010. Eur J Pharmacol. 646: 22-30. PMID: 20727878
  8. Acetylcholine receptor: covalent attachment of depolarizing groups at the active site.  |  Silman, I. and Karlin, A. 1969. Science. 164: 1420-1. PMID: 5783718
  9. Interaction of spin-labeled Naja naja siamensis alpha-neurotoxin with acetylcholine receptor from Torpedo californica.  |  Ellena, JF. and McNamee, MG. 1980. FEBS Lett. 110: 301-4. PMID: 7371834
  10. Acquired megacolon is associated with alteration of vasoactive intestinal peptide levels and acetylcholinesterase activity.  |  Koch, TR., et al. 1993. Regul Pept. 48: 309-19. PMID: 7506433
  11. Where does cholesterol act during activation of the nicotinic acetylcholine receptor?  |  Addona, GH., et al. 1998. Biochim Biophys Acta. 1370: 299-309. PMID: 9545586
  12. Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function.  |  Sastry, BV. and Hemontolor, ME. 1998. J Ocul Pharmacol Ther. 14: 447-58. PMID: 9811234
  13. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine.  |  Rama Sastry, BV., et al. 1999. Pharmacology. 58: 70-86. PMID: 9873232

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Bromoacetylcholine bromide, 500 mg

sc-252517
500 mg
$403.00